1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Switzerland >
  5. Genfit Acquires Versantis

M&A Deal Summary

Genfit Acquires Versantis

On September 19, 2022, Genfit acquired life science company Versantis

Acquisition Highlights
  • This is Genfit’s 1st transaction in the Life Science sector.
  • This is Genfit’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2022-09-19
Target Versantis
Sector Life Science
Buyer(s) Genfit
Deal Type Add-on Acquisition

Target

Versantis

Zurich, Switzerland
Versantis is a clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases. Versantis is based in Zurich, Switzerland.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Genfit

Loos, France
Category Company
Founded 1999
Sector Life Science
Employees180
Revenue 67M EUR (2024)
DESCRIPTION

Genfit is a biopharmaceutical company. It specializes in the discovery and development of drugs for preventing and treating risk factors related to cardiometabolic pathologies (atherosclerosis, dyslipidemias, hypertension, diabetes, obesity, etc.) and inflammatory diseases. Genfit was founded in 1999 and is based in Loos, France.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Switzerland M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal